In testimony before Congress last week, by DEA acting administrator Robert Patterson opined that the medicalization of cannabis is exacerbating opioid abuse. But when prompted to provide evidence in support of the agency’s position, he acknowledged that he could not.
Click here to subscribe to NORMLtv and receive alerts whenever new content is added. The…
[Editor’s note: This post is excerpted from this week’s forthcoming NORML weekly media advisory. To…
First Unveiling of New Strain To Redefine The Medical Cannabis Industry New Released Scientific Data…
Let’s hope the DEA’s answers are as illuminating as the questions being asked by Chairman Conyers.